Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
100Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0.00 | $-6.61M | $-0.16 |
| 2024 | $0.00 | $-162.26M | $-4.46 |
| 2023 | $4.49M | $-1.47B | $-17.62 |
| 2022 | $-10.70M | $-967.52M | $-30.38 |
| 2021 | $88.03M | $-2.33B | $-30.70 |
Social Signal Score
Earnings
Typical surprise +29.2% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Jul 30$-0.22 vs $-0.01miss
- Thu, Dec 18$-0.08 vs $-0.06miss
- Tue, Aug 26$-0.03 vs $-0.06beat
- Thu, May 15$-0.02 vs $-0.06beat
- Mon, Mar 31$-0.06 vs $-0.06beat
- Thu, Nov 14$-0.25 vs $-0.16miss
Estimates and results for NBP via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
NBPhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (1)
- Newsglobenewswire.com·1d ago·Neutral
… 2026 Financial Results and Provide a Corporate Update on Thursday, August 20, 2026 ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a global biotechnology company that identifies differentiated innovation and applies disciplined development, financing, and partnering strategies to create value, today announced that it will hold a webcast on Thursday, August 20, 2026 at 9:00 AM ET/9:00 PM China Standard Time to discuss recent…
View source ↗